Table 3.
1H NMR and 13C NMR for compound 8 and gymnastatin H in CDCl3 (δ in ppm, J in Hz).
Pos. | 8a | gymnastatin Hb | ||
---|---|---|---|---|
δ H | δ C | δ H | δ C | |
1a | 3.71, m | 64.4, CH2 | 172.3, C | |
1b | 3.61, dd (5.2, 10.8) | |||
2 | 4.22, m | 53.3, CH | 4.97, dt (7.8, 5.8) | 53.3, CH |
3 | 2.82, d (6.0) | 36.2, CH2 | a 3.06, dd (14.1, 5.8) | 37.3, CH2 |
b 3.13, dd (14.1, 5.8) | ||||
4 | — | 129.1, C | — | 127.8, C |
5/9 | 7.06, d (8.0) | 130.2, CH | 6.97, d (8.5) | 130.5, CH |
6/8 | 6.78, d (7.6) | 115.6, CH | 6.74, d (8.5) | 115.5, CH |
7 | — | 154.8, C | — | 154.8, C |
10 | 5.86, d (7.6) | — | 5.94, d (7.8) | — |
11 | — | 167.6, C | — | 166.2, C |
12 | 5.71, d (15.2) | 117.2, CH | 5.73, d (15.3) | 117.1, CH |
13 | 7.23, d (15.2) | 147.1, CH | 7.24, d (15.3) | 147.2, CH |
14 | — | 130.8, C | — | 130.9, C |
15 | 5.64, d (9.6) | 148.2, CH | 5.64, d (9.8) | 148.2, CH |
16 | 2.49, m | 33.2, CH | 2.51, m | 33.2, CH |
17a | 1.27, m | 37.2, CH2 | 1.26, m | 37.3, CH2 |
17b | 1.33, m | 1.33, m | ||
18 | 1.24, m | 27.5, CH2 | 1.22, m | 27.5, CH2 |
19 | 1.24, m | 29.3, CH2 | 1.22, m | 29.4, CH2 |
20 | 1.24, m | 29.7, CH2 | 1.23, m | 31.8, CH2 |
21 | 1.24, m | 29.6, CH2 | 1.25, m | 22.7, CH2 |
22 | 1.24, m | 31.9, CH2 | 0.88, t (6.7) | 14.1, CH3 |
23 | 1.33, m | 22.7, CH2 | 1.75, s | 12.5, CH3 |
24 | 0.88, t (6.4, 13.6) | 14.1, CH3 | 0.97, d (6.6) | 20.6, CH3 |
25 | 1.74, s | 12.5, CH3 | — | — |
26 | 0.97, d (6.8) | 20.5, CH3 | — | — |
aSpectra were recorded at 400 MHz for 1H and at 100 MHz for 13C in CDCl3.
bSpectra were recorded at 300 MHz 1H and at 75 MHz for 13C in CDCl3.